Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,21S,24S,27S)-27,31-diamino-14-((S)-2-((S)-6-amino-2-((S)-2,6-diaminohexanamido)hexanamido)-6-(4-boronobenzamido)hexanamido)-24-(4-aminobutyl)-21-(4-(4-boronobenzamido)butyl)-11-(4-boronobenzyl)-2-(4-hydroxybenzyl)-8-((R)-1-hydroxyethyl)-5-(hydroxymethyl)-4,7,10,13,20,23,26-heptaoxo-3,6,9,12,19,22,25-heptaazahentriacontan-1-oic acid
ID: ALA4518051
PubChem CID: 155541297
Max Phase: Preclinical
Molecular Formula: C81H127B3N18O23
Molecular Weight: 1753.45
Molecule Type: Unknown
Associated Items: